T1	chemical 0 10	Metamizole
T2	disease_or_phenotypic_feature 28 34	injury
T3	disease_or_phenotypic_feature 221 232	Sensitivity
T4	disease_or_phenotypic_feature 339 368	multiple chemical sensitivity
T5	chemical 348 356	chemical
T6	disease_or_phenotypic_feature 369 374	(MCS)
T7	chemical 430 433	sec
T8	chemical 435 438	sed
T9	disease_or_phenotypic_feature 455 458	sei
T10	chemical 535 544	Sorafenib
T11	chemical 578 587	inhibitor
T12	disease_or_phenotypic_feature 635 652	pancreatic cancer
T13	chemical 706 718	mitoxantrone
T15	disease_or_phenotypic_feature 773 787	carcinosarcoma
T16	chemical 839 843	drug
T17	chemical 1016 1020	drug
T18	disease_or_phenotypic_feature 1046 1058	brain tumors
T19	chemical 1089 1099	inhibitors
T20	disease_or_phenotypic_feature 1103 1110	uveitis
T21	chemical 1133 1142	serotonin
T22	chemical 1164 1173	biomarker
T23	disease_or_phenotypic_feature 1178 1184	autism
T24	disease_or_phenotypic_feature 1223 1229	cancer
T25	chemical 1230 1234	drug
T26	chemical 1363 1369	oxygen
T27	chemical 1438 1446	estrogen
T28	chemical 1480 1492	progesterone
T29	disease_or_phenotypic_feature 1549 1562	breast cancer
T30	chemical 1653 1663	carbon-ion
T32	disease_or_phenotypic_feature 1681 1704	head and neck carcinoma
T33	chemical 1723 1738	Povidone-iodine
T34	disease_or_phenotypic_feature 1754 1762	cataract
T35	chemical 1822 1830	Gartanin
T36	chemical 1949 1955	enzyme
T37	disease_or_phenotypic_feature 1957 1960	NAE
T38	disease_or_phenotypic_feature 2080 2095	prostate cancer
T39	disease_or_phenotypic_feature 2202 2219	pancreatic cancer
T40	disease_or_phenotypic_feature 2239 2256	pancreatic cancer
T41	chemical 2257 2262	group
T42	disease_or_phenotypic_feature 2303 2311	diseases
T43	disease_or_phenotypic_feature 2338 2345	disease
T44	chemical 2346 2351	group
T45	chemical 2385 2395	anesthesia
T46	disease_or_phenotypic_feature 2405 2413	cataract
T47	disease_or_phenotypic_feature 2423 2434	Hypotensive
T48	chemical 2435 2445	anesthesia
T49	chemical 2486 2494	propofol
T50	chemical 2508 2518	isoflurane
T51	chemical 2526 2540	Apolipoprotein
T52	chemical 2570 2577	Protein
T53	disease_or_phenotypic_feature 2633 2650	Colorectal Cancer
T54	chemical 2684 2693	glucoside
T55	chemical 2705 2714	oxidative
T56	disease_or_phenotypic_feature 2752 2760	cataract
T57	disease_or_phenotypic_feature 2784 2803	psoriatic arthritis
T58	disease_or_phenotypic_feature 2808 2817	psoriasis
T59	chemical 2858 2867	inhibitor
T60	chemical 2868 2878	infliximab
T61	chemical 2892 2906	growth-hormone
T62	disease_or_phenotypic_feature 2929 2942	hyperglycemia
T63	corrected_disease_or_phenotypic_feature 21 34	kidney injury
R1	causes_or_contributes_to Arg1:T1 Arg2:T63	
T64	corrected_chemical 566 587	multikinase inhibitor
T65	missed_disease_or_phenotypic_feature 617 623	tumors
R2	treats Arg1:T13 Arg2:T15	
T67	missed_disease_or_phenotypic_feature 803 814	RG-2 tumors
T71	corrected_chemical 1067 1099	tumor necrosis factor inhibitors
T72	missed_chemical 1147 1160	interleukin-6
T73	missed_chemical 1334 1355	antineoplastic agents
T75	missed_chemical 1280 1321	bioreductive (hypoxia-activated) prodrugs
T76	missed_disease_or_phenotypic_feature 1403 1417	breast cancers
R3	treats Arg1:T30 Arg2:T32	
T79	missed_disease_or_phenotypic_feature 1617 1646	nasolacrimal duct obstruction
T86	corrected_disease_or_phenotypic_feature 2285 2311	benign pancreatic diseases
T87	corrected_disease_or_phenotypic_feature 2331 2345	benign disease
T88	corrected_chemical 2377 2395	topical anesthesia
T89	corrected_chemical 2559 2577	C-Reactive Protein
T90	corrected_chemical 2526 2544	Apolipoprotein A-I
T91	corrected_chemical 2669 2693	Isorhamnetin-3-glucoside
T93	missed_disease_or_phenotypic_feature 2726 2739	opacification
R12	treats Arg1:T91 Arg2:T93	
R13	treats Arg1:T91 Arg2:T56	
T95	corrected_disease_or_phenotypic_feature 2808 2826	psoriasis vulgaris
T96	corrected_chemical 2836 2867	tumor necrosis factor inhibitor
R14	treats Arg1:T96 Arg2:T57	
R15	treats Arg1:T96 Arg2:T95	
T97	corrected_disease_or_phenotypic_feature 2920 2942	neonatal hyperglycemia
T98	missed_chemical 2880 2887	Insulin
R16	treats Arg1:T98 Arg2:T97	
R18	treats Arg1:T10 Arg2:T65	
R19	treats Arg1:T10 Arg2:T12	
R20	treats Arg1:T64 Arg2:T65	
R21	treats Arg1:T64 Arg2:T12	
T99	missed_disease_or_phenotypic_feature 740 761	drug-resistant tumors
R22	treats Arg1:T13 Arg2:T99	
R23	treats Arg1:T71 Arg2:T20	
R24	treats Arg1:T75 Arg2:T24	
R25	treats Arg1:T73 Arg2:T24	
R6	treats Arg1:T61 Arg2:T97	
T14	missed_disease_or_phenotypic_feature 663 678	adverse effects
R7	causes_or_contributes_to Arg1:T13 Arg2:T14	
T31	missed_disease_or_phenotypic_feature 1739 1749	antisepsis
R8	causes_or_contributes_to Arg1:T30 Arg2:T79	
R4	treats Arg1:T60 Arg2:T95	
R9	treats Arg1:T60 Arg2:T57	
T66	missed_chemical 155 165	medication
R5	causes_or_contributes_to Arg1:T66 Arg2:T63	
R10	treats Arg1:T25 Arg2:T24	
R17	treats Arg1:T17 Arg2:T18	
R26	treats Arg1:T16 Arg2:T67	
T68	missed_chemical 2743 2751	selenite
R11	causes_or_contributes_to Arg1:T68 Arg2:T56	
